Gene · 51135
Papers3,419
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 3,419
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The effects of immune checkpoint modulators on the clinical course of patients with resectable hepatocellular carcinoma. | J Liver Cancer | 2022 | 37383538 | PubTator, text mining | PubMed |
| Establishment and external verification of an oxidative stress-related gene signature to predict clinical outcomes and therapeutic responses of colorectal cancer. | Front Pharmacol | 2022 | 36860211 | PubTator, text mining | PubMed |
| Bioinformatic identification of potential biomarkers and therapeutic targets in carotid atherosclerosis and vascular dementia. | Front Neurol | 2022 | 36703641 | PubTator, text mining | PubMed |
| Biological properties and surgical applications of the human amniotic membrane. | Front Bioeng Biotechnol | 2022 | 36698632 | PubTator, text mining | PubMed |
| Proteomic Characterization of PAMs with PRRSV-ADE Infection. | Viruses | 2022 | 36680075 | PubTator, text mining | PubMed |
| Frequency of Pathogenic Germline Mutations in Early and Late Onset Familial Breast Cancer Patients Using Multi-Gene Panel Sequencing: An Egyptian Study. | Genes (Basel) | 2022 | 36672847 | PubTator, text mining | PubMed |
| Differential Gene Expression Induced by Different TLR Agonists in A549 Lung Epithelial Cells Is Modulated by CRISPR Activation of TLR10. | Biomolecules | 2022 | 36671404 | PubTator, text mining | PubMed |
| S100A8 and S100A12 Proteins as Biomarkers of High Disease Activity in Patients with Rheumatoid Arthritis That Can Be Regulated by Epigenetic Drugs. | Int J Mol Sci | 2022 | 36614150 | PubTator, text mining | PubMed |
Inhibitory Mechanism of IL-6 Production by Orento in Oral Squamous Cell Carcinoma Cell Line CAL27 Stimulated by Pathogen-Associated Molecular Patterns from Periodontopathogenic Porphyromonas gingivalis. | Int J Mol Sci | 2022 | 36614140 | PubTator, text mining | PubMed |
| Toll-like Receptors and Celiac Disease. | Int J Mol Sci | 2022 | 36613709 | PubTator, text mining | PubMed |
| TLR9 and Glioma: Friends or Foes? | Cells | 2022 | 36611945 | PubTator, text mining | PubMed |
| The mechanism study of Miao medicine Tongfengting decoction in the treatment of gout based on network pharmacology and molecular docking. | Medicine (Baltimore) | 2022 | 36595750 | PubTator, text mining | PubMed |
| The relationship between chronic immune response and neurodegenerative damage in long COVID-19. | Front Immunol | 2022 | 36591299 | PubTator, text mining | PubMed |
| Aberrant B-Cell Activation in Systemic Lupus Erythematosus. | Kidney Dis (Basel) | 2022 | 36590680 | PubTator, text mining | PubMed |
| Crosstalk between mitophagy and innate immunity in viral infection. | Front Microbiol | 2022 | 36590405 | PubTator, text mining | PubMed |
| Neuro-immune-endocrine mechanisms with poor adherence to aromatase inhibitor therapy in breast cancer. | Front Oncol | 2022 | 36578931 | PubTator, text mining | PubMed |
| JC2-11, a benzylideneacetophenone derivative, attenuates inflammasome activation. | Sci Rep | 2022 | 36577816 | PubTator, text mining | PubMed |
| Potential bioactive compounds and mechanisms of Fibraurea recisa Pierre for the treatment of Alzheimer's disease analyzed by network pharmacology and molecular docking prediction. | Front Aging Neurosci | 2022 | 36570530 | PubTator, text mining | PubMed |
| Antimicrobial peptides could antagonize uncontrolled inflammation via Toll-like 4 receptor. | Front Bioeng Biotechnol | 2022 | 36568291 | PubTator, text mining | PubMed |
| Evolutionary divergence in the conformational landscapes of tyrosine vs serine/threonine kinases. | Elife | 2022 | 36562610 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51135/papers?page=29